About Ribo
Science
Pipeline
Investors
Careers
Contact
About Ribo
International R&D Center
Our Culture
News
About Oligonucleotide Therapeutics
Technological Innovations
Intellectual Property
Pipeline
Products
Key Clinical Trials
Overview
Our Culture
Career Development
Recruitment
BD and Collaboration
Contact Information
CN
B3-pcbanner.jpg B3-phbanner.jpg
News
About RiboNews
Ribo Closed $40M Series E1 Financing to support global development of the diversified pipelines and continuous advancement of siRNA technologies.
Jul 29,2022
Last : Ribo Announces China CDE Approval of Clinical Trial Application of RBD7022 First-In-Human Clinical Trial in China for Treatment of Hyperlipidemia.
Next : Ribocure Pharmaceuticals Moves Into GoCo Clinic - Putting North Europe in the Spotlight Within Oligonucleotide Therapeutics
世界杯竞猜官网-腾讯体育 | 开云下注-百度百科 | 开云-开云体育官网(中国)有限公司 | 彩神大发app下载中国有限公司 | 亚搏下注买球（中国）有限公司 | 世界杯押注官网（集团）有限公司 | 网上买球线上平台|中国有限公司 | 世界杯怎么押注(中国)有限公司 | 火狐体育官网入口-中国体育品牌 |